仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Bavituximab （Anti-Human Phosphatidylserine Recombinant Antibody） is a phosphatidylserine （PS）-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity. Bavituximab plus Paclitaxel （HY-B0015） and Carboplatin （HY-17393）, have enhanced inhibition on non-small-cell lung cancer